tailieunhanh - Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: A report of two cases

Multiple new targeted agents have been developed for patients with human epidermal growth factor receptor type 2 (HER2) – positive breast cancer. Patients with HER2– positive breast cancer will develop brain metastases with greater incidence than patients with non-HER2 cancers, and many of them will undergo stereotactic radiosurgery (SRS) or other CNS radiotherapy. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN